Abstract:Hepatitis E virus (HEV) is one of the causative agents for liver inflammation across the world. HEV is a positive-sense single-stranded RNA virus. Human HEV strains mainly belong to four major genotypes in the genus Orthohepevirus A, family Hepeviridae. Among the four genotypes, genotype 1 and 2 are obligate human pathogens, and genotype 3 and 4 cause zoonotic infections. HEV infection with genotype 1 and 2 mainly presents as acute and self-limiting hepatitis in young adults. However, HEV infection of pregnant… Show more
“…Thus, higher mortality of epidemic hepatitis E in pregnancy is genotype-specific and associated with HEV-gt1 and not with other genotypes causing human infections, namely HEV-gt2, HEV-gt3, and HEV-gt4. However, adverse pregnancy outcomes including miscarriage and stillbirths have been reported in pregnant rabbits experimentally infected with HEV-gt3 and HEV-gt4 [ 122 , 123 , 124 ].…”
Section: Epidemic Hepatitis E and Pregnancymentioning
confidence: 99%
“…Among the HEV family, HEV-gt1 alone has ORF4 which encodes a protein, pORF4 of 124 aa [ 38 , 39 ]. The encoded pORF4 by the HEV-gt1 genome interact with other viral and host proteins, enhance viral polymerase activity and promote viral replication [ 123 ]. HEV-gt1, and not HEV-gt3, causes necrosis and apoptosis in the maternal–fetal interface possibly caused by mitochondrial damage and activation of caspase family membranes [ 151 ].…”
Section: Proposed Hypothesis On Pathogenesis Of Mortality In Hev-infected Pregnant Womenmentioning
confidence: 99%
“…HEV-gt1 infection in pregnant women causes several alterations in innate and adaptive immune response, which helps virus replication and increases the severity of disease in the pregnant women [ 123 ]. Pregnant women with HEV-ALF have impaired macrophage phagocytic activity and downregulation of TLR3 and TLR9 expression, impeding MyD88-mediated IFN production [ 158 ].…”
Section: Proposed Hypothesis On Pathogenesis Of Mortality In Hev-infected Pregnant Womenmentioning
The adverse relationship between viral hepatitis and pregnancy in developing countries had been interpreted as a reflection of retrospectively biased hospital-based data collection by the West. However, the discovery of hepatitis E virus (HEV) as the etiological agent of an epidemic of non-A, non-B hepatitis in Kashmir, and the documenting of the increased incidence and severity of hepatitis E in pregnancy via a house-to-house survey, unmasked this unholy alliance. In the Hepeviridae family, HEV-genotype (gt)1 from genus Orthohepevirus A has a unique open reading frame (ORF)4-encoded protein which enhances viral polymerase activity and viral replication. The epidemics caused by HEV-gt1, but not any other Orthohepevirus A genotype, show an adverse relationship with pregnancy in humans. The pathogenesis of the association is complex and at present not well understood. Possibly multiple factors play a role in causing severe liver disease in the pregnant women including infection and damage to the maternal-fetal interface by HEV-gt1; vertical transmission of HEV to fetus causing severe fetal/neonatal hepatitis; and combined viral and hormone related immune dysfunction of diverse nature in the pregnant women, promoting viral replication. Management is multidisciplinary and needs a close watch for the development and management of acute liver failure. (ALF). Preliminary data suggest beneficial maternal outcomes by early termination of pregnancy in patients with lower grades of encephalopathy.
“…Thus, higher mortality of epidemic hepatitis E in pregnancy is genotype-specific and associated with HEV-gt1 and not with other genotypes causing human infections, namely HEV-gt2, HEV-gt3, and HEV-gt4. However, adverse pregnancy outcomes including miscarriage and stillbirths have been reported in pregnant rabbits experimentally infected with HEV-gt3 and HEV-gt4 [ 122 , 123 , 124 ].…”
Section: Epidemic Hepatitis E and Pregnancymentioning
confidence: 99%
“…Among the HEV family, HEV-gt1 alone has ORF4 which encodes a protein, pORF4 of 124 aa [ 38 , 39 ]. The encoded pORF4 by the HEV-gt1 genome interact with other viral and host proteins, enhance viral polymerase activity and promote viral replication [ 123 ]. HEV-gt1, and not HEV-gt3, causes necrosis and apoptosis in the maternal–fetal interface possibly caused by mitochondrial damage and activation of caspase family membranes [ 151 ].…”
Section: Proposed Hypothesis On Pathogenesis Of Mortality In Hev-infected Pregnant Womenmentioning
confidence: 99%
“…HEV-gt1 infection in pregnant women causes several alterations in innate and adaptive immune response, which helps virus replication and increases the severity of disease in the pregnant women [ 123 ]. Pregnant women with HEV-ALF have impaired macrophage phagocytic activity and downregulation of TLR3 and TLR9 expression, impeding MyD88-mediated IFN production [ 158 ].…”
Section: Proposed Hypothesis On Pathogenesis Of Mortality In Hev-infected Pregnant Womenmentioning
The adverse relationship between viral hepatitis and pregnancy in developing countries had been interpreted as a reflection of retrospectively biased hospital-based data collection by the West. However, the discovery of hepatitis E virus (HEV) as the etiological agent of an epidemic of non-A, non-B hepatitis in Kashmir, and the documenting of the increased incidence and severity of hepatitis E in pregnancy via a house-to-house survey, unmasked this unholy alliance. In the Hepeviridae family, HEV-genotype (gt)1 from genus Orthohepevirus A has a unique open reading frame (ORF)4-encoded protein which enhances viral polymerase activity and viral replication. The epidemics caused by HEV-gt1, but not any other Orthohepevirus A genotype, show an adverse relationship with pregnancy in humans. The pathogenesis of the association is complex and at present not well understood. Possibly multiple factors play a role in causing severe liver disease in the pregnant women including infection and damage to the maternal-fetal interface by HEV-gt1; vertical transmission of HEV to fetus causing severe fetal/neonatal hepatitis; and combined viral and hormone related immune dysfunction of diverse nature in the pregnant women, promoting viral replication. Management is multidisciplinary and needs a close watch for the development and management of acute liver failure. (ALF). Preliminary data suggest beneficial maternal outcomes by early termination of pregnancy in patients with lower grades of encephalopathy.
“…In the case of zoonotic viruses, distinct lineages can originate when the same virus species is introduced from different animal reservoirs, which could support ongoing diversification and lineage turnover not observed in the human population. This is how some Orthohepevirus A (OHVA) GLs (37) and possibly some TBEV and WNV GLs (33,38) could originate. However, even in this case, the maintenance of multiple niches with low turnover within human populations requires spatiotemporal or immunological separation.…”
Section: Most Virus Lineages Are Not Regionally or Seasonally Definedmentioning
confidence: 99%
“…S17). Both these genes are likely to be involved in host adaptation following zoonosis (37,48). Further, a two to five fold increase in mean dN/dS was detected for DENV, WNV and HCV GLs across most genes relative to the complete phylogeny (Fig.…”
Section: Selective Pressures Acting On Human Rna Virusesmentioning
Many pathogenic viruses are endemic among human populations and can cause a broad variety of diseases, some potentially leading to devastating pandemics. How virus populations maintain diversity and what selective pressures drive population turnover, is not thoroughly understood. We conducted a large-scale phylodynamic analysis of 27 human pathogenic RNA viruses spanning diverse life history traits in search of unifying trends that shape virus evolution. For most virus species, we identify multiple, co-circulating lineages with low turnover rates. These lineages appear to be largely noncompeting and likely occupy semi-independent epidemiological niches that are not regionally or seasonally defined. Typically, intra-lineage mutational signatures are similar to inter-lineage signatures. The principal exception are members of the family Picornaviridae, for which mutations in capsid protein genes are primarily lineage-defining. The persistence of virus lineages appears to stem from limited outbreaks within small communities so that only a minor fraction of the global susceptible population is infected at any time. As disparate communities become increasingly connected through globalization, interaction and competition between lineages might increase as well, which could result in changing selective pressures and increased diversification and/or pathogenicity. Thus, in addition to zoonotic events, ongoing surveillance of familiar, endemic viruses appears to merit global attention with respect to the prevention or mitigation of future pandemics.SignificanceNumerous pathogenic viruses are endemic in humans and cause a broad variety of diseases, but what is their potential of causing new pandemics? We show that most human pathogenic RNA viruses form multiple, co-circulating lineages with low turnover rates. These lineages appear to be largely noncompeting and occupy distinct epidemiological niches that are not regionally or seasonally defined, and their persistence appears to stem from limited outbreaks in small communities so that a minor fraction of the global susceptible population is infected at any time. However, due to globalization, interaction and competition between lineages might increase, potentially leading to increased diversification and pathogenicity. Thus, endemic viruses appear to merit global attention with respect to the prevention of future pandemics.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.